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Introduction 
Luekemic infiltration of the prostate is unusual. Acute urinary retention as an initial presentation of
chronic lymphocytic leukemia is found only in sporadic cases. Organ confmed adenocarcinoma of
prostate associated with chronic lymphocytic leukemia and presenting as acute urinary retention is to
our knowledge not reported in literature. This report documents a case of acute urinary retention in a
74-year-old man with chronic lymphocytic leukemia and adenocarcinoma of the prostate.
Case Report 
A 74-year-old male presented to the Emergency Room with a 20-hour history of acute urinary
retention. He has been troubled with mild to moderate irritative lower urinary tract symptoms, which
were not bothersome. When catheterized in the emergency room 1500 cc of urine drained in the first 15
minutes. The past history revealed hypertension (well controlled), coronary artery by-pass grafting in
1984 for ischemic heart disease, although at present, his cardiovascular status was unremarkable.
Digital rectal examination showed a moderately enlarged benign feeling prostate with firm consistency
but no nodularity. Since past history of Lower Urinary Tract Symptoms (LUTS) was mild, he was
given a trial without catheter after commencement of a-blocker (Terazosin). This, however, failed and
he was re-catheterized. His preoperative haemoglobin, hematocrit and total leukocyte counts were
normal. An uneventful transurethral resection of prostate was done and he was discharged on the
second postoperative day after successfully removing the catheter. Later his histopathology revealed
leukciiiic infiltration with 10% chips showing a well-differentiated adenocarcinoma of the prostate
(Figures 1 and 2).

Gleason sum was 2+1=3. Serum PSA was 2.1 ng/ml (0-Sng/ml). The bone scan was negative for any
metastatic disease. The leukernic infiltrate of the prostate was LCA +ve and cytokeratin -ye. The blood
film was highly suggestive of chronic lymphocytic leukemia, his post-operative haemoglobin
concentration was 13.6 gm%(11 - 15.5 gm/dl), white blood cell count was 6x109 (4-10) with 47%
lymphocytes and platelet count was also normal. Consultations with the haematologist and oncologists
derived a consensus that no further treatment was indicated at that stage. Regular follow-ups were
recommended and further intervention would only be indicated if haemoglobin and platelet counts
showed a decline. Watchful waiting was adopted with regular serum PSA and digitial rectal
examinations to monitor the prostate cancer status.
Discussion 
Leukemic infiltration of the prostate is unusual. Most commonly encountered pathology is chronic
lymphocytic leukemia. In 1973, Butler and O’Flym1 detected 6 cases of CLL among 4863 consecutive
prostatectomies. In a necropsy study of 5962 male subjects with various types of cancer, Zein et al2
found 18 cases of CLL infiltrating the prostate gland among 88 cases of CLL (20.4%). Seventy seven
patients died of leukemia showed leukemic involvmenet of the prostate among 776 autopsied leukemia
patients (10%).
To our knowledge, prostate cancer associated with chronic lymphocytic leukemia has only been
reported once3 in a patient with Klinefelter syndrome with XXY karyotype. Terris et al4 assessed the
clinical impact of haematolymphoid malignancies in a retrospective review, discovered during 1092
radical prostatectomies. The overall incidence in their experience was 1 .2%. Of these, there were 9
cases of CLL for which no further treatment was needed. In their opinion majority of ahematolymphoid
malignancies discovered at radical prostatectomy do not require further treatment.
Well differentiated adenocarcinoma of prostate with a low Gleason sum in a 74 year old male can be
managed by expectant means. Clinically, isolated prostatic involvement by leukemia is generally
managed by observation alone5. In our patient due to low potential for progression and relatively
benign natural history of both conditions, considered separately, we opted for watchful waiting which
concurred with the wishes of the patient too.
References 
1. Butler MR. O’Flynn JD. Prostatic disease in leukemic patients with particular reference to leukemic
infiltration of the prostate - a retrospective clinical study. Br. J. Urol. 1973;45:179-83.
2. Zein TA, Huben R, Lane W, et al. Secondary tumors of the prostate. J. Urol., 1985;1 33:6 15-16.
3. Pienkos EJ, Meisner LF. Adenocarcinoina of the prostate in a 41 year old man with XXY karyotype
and chronic lymphocytic leukemia: report of a case. J. Urol., 1991;145:148-50.
4. Terris MK, Hausdorff J Freiha FS. Hematolyinphoid malignancies diagnosed at the time of radical
prostatectomy. J. Urol., 1997;158:1457-9.
5. Mellemgaard A, Geisler CH, Storm HH. Risk of kidney cancer and other second solid malignancies
in patients with chronic lymphocytic leukemia. Eur. J. Haematol., 1994;53(4):218-22.
